182 related articles for article (PubMed ID: 16484323)
1. Coding GNAS mutations leading to hormone resistance impair in vitro agonist- and cholera toxin-induced adenosine cyclic 3',5'-monophosphate formation mediated by human XLalphas.
Linglart A; Mahon MJ; Kerachian MA; Berlach DM; Hendy GN; Jüppner H; Bastepe M
Endocrinology; 2006 May; 147(5):2253-62. PubMed ID: 16484323
[TBL] [Abstract][Full Text] [Related]
2. Potent constitutive cyclic AMP-generating activity of XLαs implicates this imprinted GNAS product in the pathogenesis of McCune-Albright syndrome and fibrous dysplasia of bone.
Mariot V; Wu JY; Aydin C; Mantovani G; Mahon MJ; Linglart A; Bastepe M
Bone; 2011 Feb; 48(2):312-20. PubMed ID: 20887824
[TBL] [Abstract][Full Text] [Related]
3. Extra-long Gαs variant XLαs protein escapes activation-induced subcellular redistribution and is able to provide sustained signaling.
Liu Z; Turan S; Wehbi VL; Vilardaga JP; Bastepe M
J Biol Chem; 2011 Nov; 286(44):38558-38569. PubMed ID: 21890629
[TBL] [Abstract][Full Text] [Related]
4. Functional characterization of GNAS mutations found in patients with pseudohypoparathyroidism type Ic defines a new subgroup of pseudohypoparathyroidism affecting selectively Gsα-receptor interaction.
Thiele S; de Sanctis L; Werner R; Grötzinger J; Aydin C; Jüppner H; Bastepe M; Hiort O
Hum Mutat; 2011 Jun; 32(6):653-60. PubMed ID: 21488135
[TBL] [Abstract][Full Text] [Related]
5. GNAS gene mutations affecting XLαs and bone health: A long neglected relationship.
Xie Y; Chen X; Xie Y; Yu X
Clin Genet; 2023 Sep; 104(3):279-286. PubMed ID: 37249323
[TBL] [Abstract][Full Text] [Related]
6. Stimulatory G protein directly regulates hypertrophic differentiation of growth plate cartilage in vivo.
Bastepe M; Weinstein LS; Ogata N; Kawaguchi H; Jüppner H; Kronenberg HM; Chung UI
Proc Natl Acad Sci U S A; 2004 Oct; 101(41):14794-9. PubMed ID: 15459318
[TBL] [Abstract][Full Text] [Related]
7. Transgenic overexpression of the extra-large Gsα variant XLαs enhances Gsα-mediated responses in the mouse renal proximal tubule in vivo.
Liu Z; Segawa H; Aydin C; Reyes M; Erben RG; Weinstein LS; Chen M; Marshansky V; Fröhlich LF; Bastepe M
Endocrinology; 2011 Apr; 152(4):1222-33. PubMed ID: 21303955
[TBL] [Abstract][Full Text] [Related]
8. GNAS mutations and heterotopic ossification.
Bastepe M
Bone; 2018 Apr; 109():80-85. PubMed ID: 28889026
[TBL] [Abstract][Full Text] [Related]
9. Functional polymorphisms in the paternally expressed XLalphas and its cofactor ALEX decrease their mutual interaction and enhance receptor-mediated cAMP formation.
Freson K; Jaeken J; Van Helvoirt M; de Zegher F; Wittevrongel C; Thys C; Hoylaerts MF; Vermylen J; Van Geet C
Hum Mol Genet; 2003 May; 12(10):1121-30. PubMed ID: 12719376
[TBL] [Abstract][Full Text] [Related]
10. Identification of a novel GNAS mutation in a case of pseudohypoparathyroidism type 1A with normocalcemia.
Long XD; Xiong J; Mo ZH; Dong CS; Jin P
BMC Med Genet; 2018 Jul; 19(1):132. PubMed ID: 30060753
[TBL] [Abstract][Full Text] [Related]
11. Extralarge XL(alpha)s (XXL(alpha)s), a variant of stimulatory G protein alpha-subunit (Gs(alpha)), is a distinct, membrane-anchored GNAS product that can mimic Gs(alpha).
Aydin C; Aytan N; Mahon MJ; Tawfeek HA; Kowall NW; Dedeoglu A; Bastepe M
Endocrinology; 2009 Aug; 150(8):3567-75. PubMed ID: 19423757
[TBL] [Abstract][Full Text] [Related]
12. GNAS defects identified by stimulatory G protein alpha-subunit signalling studies in platelets.
Freson K; Izzi B; Labarque V; Van Helvoirt M; Thys C; Wittevrongel C; Bex M; Bouillon R; Godefroid N; Proesmans W; de Zegher F; Jaeken J; Van Geet C
J Clin Endocrinol Metab; 2008 Dec; 93(12):4851-9. PubMed ID: 18812479
[TBL] [Abstract][Full Text] [Related]
13. The G protein α subunit variant XLαs promotes inositol 1,4,5-trisphosphate signaling and mediates the renal actions of parathyroid hormone in vivo.
He Q; Zhu Y; Corbin BA; Plagge A; Bastepe M
Sci Signal; 2015 Aug; 8(391):ra84. PubMed ID: 26307011
[TBL] [Abstract][Full Text] [Related]
14. Selective deficiency of Gsalpha and the possible role of alternative gene products of GNAS in Albright hereditary osteodystrophy and pseudohypoparathyroidism type Ia.
Thiele S; Werner R; Ahrens W; Hübner A; Hinkel KG; Höppner W; Igl B; Hiort O
Exp Clin Endocrinol Diabetes; 2010 Feb; 118(2):127-32. PubMed ID: 19658058
[TBL] [Abstract][Full Text] [Related]
15. GNAS Spectrum of Disorders.
Turan S; Bastepe M
Curr Osteoporos Rep; 2015 Jun; 13(3):146-58. PubMed ID: 25851935
[TBL] [Abstract][Full Text] [Related]
16. Autosomal-dominant pseudohypoparathyroidism type Ib is caused by different microdeletions within or upstream of the GNAS locus.
Jüppner H; Linglart A; Fröhlich LF; Bastepe M
Ann N Y Acad Sci; 2006 Apr; 1068():250-5. PubMed ID: 16831926
[TBL] [Abstract][Full Text] [Related]
17. A paternally inherited non-sense variant c.424G>T (p.G142*) in the first exon of XLαs in an adult patient with hypophosphatemia and osteopetrosis.
Chen X; Meng Y; Tang M; Wang Y; Xie Y; Wan S; Tian H; Yu X
Clin Genet; 2020 May; 97(5):712-722. PubMed ID: 32157680
[TBL] [Abstract][Full Text] [Related]
18. The GNAS locus and pseudohypoparathyroidism.
Bastepe M
Adv Exp Med Biol; 2008; 626():27-40. PubMed ID: 18372789
[TBL] [Abstract][Full Text] [Related]
19. Maternal
Cui Q; Aksu C; Ay B; Remillard CE; Plagge A; Gardezi M; Dunlap M; Gerstenfeld LC; He Q; Bastepe M
Front Genet; 2021; 12():680537. PubMed ID: 34220953
[No Abstract] [Full Text] [Related]
20. New mutations at the imprinted Gnas cluster show gene dosage effects of Gsα in postnatal growth and implicate XLαs in bone and fat metabolism but not in suckling.
Eaton SA; Williamson CM; Ball ST; Beechey CV; Moir L; Edwards J; Teboul L; Maconochie M; Peters J
Mol Cell Biol; 2012 Mar; 32(5):1017-29. PubMed ID: 22215617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
